Anne M Suskind1, Shoujun Zhao1, W John Boscardin2, Alexander Smith3, Emily Finlayson4. 1. Department of Urology, University of California, San Francisco, California. 2. Department of Epidemiology and Biostatistics, University of California, San Francisco, California. 3. Department of Medicine, Division of Geriatrics and Palliative Medicine, University of California, San Francisco, California. 4. Department of Surgery, University of California, San Francisco, California.
Abstract
OBJECTIVES: To understand where older adults spend time (at home, in the hospital, or in a nursing home) in the year following high-risk cancer surgery. DESIGN: Retrospective cohort study. SETTING: Medicare beneficiaries using data from Medicare Inpatient claims to ascertain hospital days and the Minimum Data Set to ascertain nursing home days. PARTICIPANTS: Beneficiaries who underwent high-risk cancer surgery (cystectomy, pancreaticoduodenectomy, gastrectomy, or esophagectomy) were identified to determine cumulative time spent away from home in the year following surgery. MEASUREMENTS: Adjusted percentages of time spent away from home (ie, days in a hospital or nursing home) were modeled for the year following surgery. RESULTS: A total of 37 748 beneficiaries underwent high-risk cancer surgery during the study period, and 28.3% died within 1 year. Overall, beneficiaries spent 13.9 ± 26.2 days in the hospital (over 1.5 ± 2.0 hospital readmissions) and 37.2 ± 50.6 days in the nursing home (over 1.5 ± 1.0 admissions) in the year following surgery. Among beneficiaries who were alive and dead at 1 year, 18.5% and 30.1% of time was spent away from home, respectively. Beneficiaries who were initially discharged to a facility following surgery and died within 1 year spent 44.4% of their final year away from home. CONCLUSION: Time spent away from home in the hospital and/or nursing home in the year following high-risk cancer surgery is substantial among Medicare beneficiaries. This information is crucial in counseling patients on postoperative expectations and may additionally influence preoperative decision making. J Am Geriatr Soc 68:505-510, 2020.
OBJECTIVES: To understand where older adults spend time (at home, in the hospital, or in a nursing home) in the year following high-risk cancer surgery. DESIGN: Retrospective cohort study. SETTING: Medicare beneficiaries using data from Medicare Inpatient claims to ascertain hospital days and the Minimum Data Set to ascertain nursing home days. PARTICIPANTS: Beneficiaries who underwent high-risk cancer surgery (cystectomy, pancreaticoduodenectomy, gastrectomy, or esophagectomy) were identified to determine cumulative time spent away from home in the year following surgery. MEASUREMENTS: Adjusted percentages of time spent away from home (ie, days in a hospital or nursing home) were modeled for the year following surgery. RESULTS: A total of 37 748 beneficiaries underwent high-risk cancer surgery during the study period, and 28.3% died within 1 year. Overall, beneficiaries spent 13.9 ± 26.2 days in the hospital (over 1.5 ± 2.0 hospital readmissions) and 37.2 ± 50.6 days in the nursing home (over 1.5 ± 1.0 admissions) in the year following surgery. Among beneficiaries who were alive and dead at 1 year, 18.5% and 30.1% of time was spent away from home, respectively. Beneficiaries who were initially discharged to a facility following surgery and died within 1 year spent 44.4% of their final year away from home. CONCLUSION: Time spent away from home in the hospital and/or nursing home in the year following high-risk cancer surgery is substantial among Medicare beneficiaries. This information is crucial in counseling patients on postoperative expectations and may additionally influence preoperative decision making. J Am Geriatr Soc 68:505-510, 2020.
Authors: Jeffrey M Sutton; Gregory C Wilson; Koffi Wima; Richard S Hoehn; R Cutler Quillin; Dennis J Hanseman; Ian M Paquette; Jeffrey J Sussman; Syed A Ahmad; Shimul A Shah; Daniel E Abbott Journal: Ann Surg Oncol Date: 2015-04-04 Impact factor: 5.344
Authors: Trevor D Hamilton; Alyson L Mahar; Barbara Haas; Kaitlyn Beyfuss; Calvin H L Law; Paul J Karanicolas; Natalie G Coburn; Julie Hallet Journal: Gastric Cancer Date: 2017-12-11 Impact factor: 7.370
Authors: Ibrahim Nassour; Sam C Wang; Matthew R Porembka; Adam C Yopp; Michael A Choti; Mathew M Augustine; Patricio M Polanco; John C Mansour; Rebecca M Minter Journal: J Gastrointest Surg Date: 2017-08-17 Impact factor: 3.452
Authors: Ted A Skolarus; Bruce L Jacobs; Florian R Schroeck; Chang He; Alexander M Helfand; Jonathan Helm; Michael Hu; Mariel Lavieri; Brent K Hollenbeck Journal: J Urol Date: 2014-11-04 Impact factor: 7.450
Authors: Bruce L Jacobs; Chang He; Benjamin Y Li; Alex Helfand; Naveen Krishnan; Tudor Borza; Amir A Ghaferi; Brent K Hollenbeck; Jonathan E Helm; Mariel S Lavieri; Ted A Skolarus Journal: J Surg Res Date: 2017-02-23 Impact factor: 2.192
Authors: Alexander S Rosemurgy; Kenneth Luberice; Harold Paul; Franka Co; Michelle Vice; Paul Toomey; Edward Choung; Sharona B Ross Journal: Am Surg Date: 2012-08 Impact factor: 0.688
Authors: Shipra Arya; Ashley H Langston; Rui Chen; Marzena Sasnal; Elizabeth L George; Aditi Kashikar; Nicolas B Barreto; Amber W Trickey; Arden M Morris Journal: JAMA Netw Open Date: 2022-01-04